SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950162-08-000139
Filing Date
2008-03-10
Accepted
2008-03-10 15:16:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 REGENERX - INVERLOCHY - SCHEDULE 13D/A NO. 10 inverlochy13dano10_031008.htm SC 13D/A 325861
  Complete submission text file 0000950162-08-000139.txt   327898
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 08677562
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-227
Business Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-227 650-470-4500
Inverlochy Consultadoria & Servicos L.D.A. (Filed by) CIK: 0001384386 (see all company filings)

IRS No.: 000000000 | State of Incorp.: S1 | Fiscal Year End: 1231
Type: SC 13D/A